DREADDs in humans--update:
3 clinical trials using hM4Di in humans registered in China. 2 for epilepsy and 1 for Parkinson's Disease.
In our original paper we stated:
"...We suggest that at least one of these designer receptors, hM4D, will prove useful for neuronal silencing in vitro and in vivo.."
It seems we were correct.
Huge thanks to my mentor @zenbrainest for this work and for guiding me in structural biology and pharmacology. Many thanks also to @rgumpper, Yuxuan Zhuang, and Ron Dror for the MD simulations!
I'm giving a talk on 'Molecular Glues and GPCRs'
Dr. GPCR University with Dr. Bryan Roth
Thursday, April 9 · 10:00 – 11:35 AM (America/New_York)
https://t.co/Set0Unik1Y
It's out - we isolated mGluR2 containing assemblies from brains and resolved various conformational and compositional states. A subtype-specific functional property shapes the conformational landscape. Project like this has been a dream of mine since I started my science journey
Huge implications for #GPCR-based drug and sensor design
Differential Effects of Sodium on Agonist-Induced Conformational Transitions and Signaling at μ and κ Opioid Receptors | https://t.co/w9wLk96htr
Official announcement: this September 1, the Osman laboratory will be opening its doors in the biological sciences department at SUNY, Albany!
Anyone interested in joining the lab, please contact me.
[email protected]
Lab website coming soon!
@ualbany
Thanks, Fred, for featuring our recent Neuron article in Migraine Science Collaborative!!
Psychedelics to Treat Human Disease: Many Targets, Lots of Complexity https://t.co/6vK9d1Tc93
Hugely important work from @zenbrainest that opens new doors (and immensely complicates the picture!) The polypharmacology of psychedelics reveals multiple targets for potential therapeutics: Neuron https://t.co/OvrSOjuir3
It's finally out! Our "somewhat" thorough study on psychedelic polypharmacology. Congrats to @jainmk6@zenbrainest and everyone else involved! https://t.co/9dIzRXs2ry
#psychedelics